Zhong-Dong Wang1, Fan-Yong Qu2, Yuan-Yuan Chen3, Zhang-Shen Ran3, Hai-Yan Liu4, Hai-Dong Zhang5. 1. Clinical Laboratory of Taishan Sanatorium of Shandong Province, Tai'an 271001, China. 2. Interventional Radiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China. 3. Center of Health Examination, Affiliated Hospital of Taishan Medical University, Tai'an 271001, China. 4. Department of Oncology, Affiliated Hospital of Taishan Medical University, Tai'an 271001, China. 5. Department of Basic Medicine, Taishan Medical University, Tai'an 271001, China.
Abstract
OBJECTIVE: Hepatocellular carcinoma (HCC) is still one of the most common death-related malignancies worldwide. Because the way onset and progression are hidden most, HCC diagnoses are made at an advanced stage, when they are unsuitable for surgical resection. MicroRNAs are a class of small non-coding RNAs, participating in many aspects of cancers. In this study, we tried to establish the role of microRNA-718 (miR-718) in the malignant phenotype of HCC cells and its possible role in HCC diagnosis. METHODS: Here we first used a methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay, Transwell migration and invasion assays, and colony formation assay to evaluate the impact of miR-718 on the malignant phenotypes of HCC cells. Then, we used bioinformatic methods to predict the target gene of miR-718 and used green fluorescence protein (GFP) reporter assay, Western blot, and quantitative real-time polymerase chain reaction (qRT-PCR) to validate the regulation relationship. Finally, we determined the role of the target gene in the HCC phenotype. RESULTS: We found that the expression of miR-718 was significantly reduced in various HCC cell lines and HCC tissues. Re-expression of miR-718 significantly reduced the cellular viability and colony formation ability as well as inhibited the migration and invasion abilities of HCC cell lines. Early growth response protein 3 (EGR3) is a direct target of miR-718 and is negatively regulated by miR-718. EGR3 could increase the viability and proliferation of HCC cells, and promot the migration and invasion of HCC cells. CONCLUSIONS: miR-718 acts as a tumor suppressive microRNA in HCC via regulating the expression of EGR3, which may provide a new diagnostic marker and treatment target for HCC.
OBJECTIVE:Hepatocellular carcinoma (HCC) is still one of the most common death-related malignancies worldwide. Because the way onset and progression are hidden most, HCC diagnoses are made at an advanced stage, when they are unsuitable for surgical resection. MicroRNAs are a class of small non-coding RNAs, participating in many aspects of cancers. In this study, we tried to establish the role of microRNA-718 (miR-718) in the malignant phenotype of HCC cells and its possible role in HCC diagnosis. METHODS: Here we first used a methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay, Transwell migration and invasion assays, and colony formation assay to evaluate the impact of miR-718 on the malignant phenotypes of HCC cells. Then, we used bioinformatic methods to predict the target gene of miR-718 and used green fluorescence protein (GFP) reporter assay, Western blot, and quantitative real-time polymerase chain reaction (qRT-PCR) to validate the regulation relationship. Finally, we determined the role of the target gene in the HCC phenotype. RESULTS: We found that the expression of miR-718 was significantly reduced in various HCC cell lines and HCC tissues. Re-expression of miR-718 significantly reduced the cellular viability and colony formation ability as well as inhibited the migration and invasion abilities of HCC cell lines. Early growth response protein 3 (EGR3) is a direct target of miR-718 and is negatively regulated by miR-718. EGR3 could increase the viability and proliferation of HCC cells, and promot the migration and invasion of HCC cells. CONCLUSIONS:miR-718 acts as a tumor suppressive microRNA in HCC via regulating the expression of EGR3, which may provide a new diagnostic marker and treatment target for HCC.
Entities:
Keywords:
miR-718; MicroRNA; Early growth response protein 3 (EGR3); Hepatocellular carcinoma (HCC); Malignant phenotype
Authors: Lin Li; Sung Hwan Yun; James Keblesh; Barbara L Trommer; Huangui Xiong; Jelena Radulovic; Warren G Tourtellotte Journal: Mol Cell Neurosci Date: 2007-02-12 Impact factor: 4.314
Authors: K Sugimachi; T Matsumura; H Hirata; R Uchi; M Ueda; H Ueo; Y Shinden; T Iguchi; H Eguchi; K Shirabe; T Ochiya; Y Maehara; K Mimori Journal: Br J Cancer Date: 2015-01-13 Impact factor: 7.640
Authors: Manjistha Sengupta; Bi-Dar Wang; Norman H Lee; Alexander Marx; Linda L Kusner; Henry J Kaminski Journal: PLoS One Date: 2018-10-11 Impact factor: 3.240